Ascend Wellness Holdings (AAWH) EBITDA Margin (2020 - 2026)

Ascend Wellness Holdings' EBITDA Margin history runs 7 years deep, the most recent figure standing at 2.18% for Q1 2026.

• On a quarterly basis, EBITDA Margin rose 24.0% year-over-year to 2.18% in Q1 2026; TTM through Mar 2026 was 3.46%, a 431.0% decrease from a year earlier, with the FY2025 full-year figure at 3.4%, down 424.0% from the prior year.
• EBITDA Margin advanced to 2.18% in Q1 2026 per AAWH's latest filing, from 14.24% in the prior quarter.
• Across five years, EBITDA Margin topped out at 4.8% in Q4 2022 and bottomed at 17.37% in Q1 2022.
• The 5-year median for EBITDA Margin is 0.22% (2023), against an average of 1.34%.
• Across the five-year window, EBITDA Margin jumped 3100 bps in 2022 and sank 1873 bps in 2025, its largest moves.
• Year by year, EBITDA Margin stood at 4.8% in 2022, then slumped by 92 bps to 0.4% in 2023, then jumped by 1014 bps to 4.48% in 2024, then tumbled by 418 bps to 14.24% in 2025, then surged by 115 bps to 2.18% in 2026.
• Per Business Quant, the three latest AAWH EBITDA Margin figures stand at 2.18% (Q1 2026), 14.24% (Q4 2025), and 1.06% (Q3 2025).